cormagnesin
worwag pharma gmbh & co. kg - magnesio - magnesio
thiogamma
worwag pharma gmbh & co. kg - acido tioctico - acido tioctico
valsartan awp
a.w.p. s.r.l. - valsartan - valsartan
gabapentin awp
a.w.p. s.r.l. - gabapentin - gabapentin
metformina awp
a.w.p. s.r.l. - metformina - metformina
sitagliptin wörwag pharma 25 mg compresse rivestite con film
maras ag - sitagliptinum - compresse rivestite con film - sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, lactosum monohydricum 1.2 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 0.62 mg. - diabetes mellitus typ 2 - synthetika
sitagliptin wörwag pharma 50 mg compresse rivestite con film
maras ag - sitagliptinum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, poly(vinylis acetas), macrogolum 3350, e 171, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.25 mg. - diabetes mellitus typ 2 - synthetika
sitagliptin wörwag pharma 100 mg compresse rivestite con film
maras ag - sitagliptinum - compresse rivestite con film - sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, poly(vinylis acetas), macrogolum 3350, e 171, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 2.5 mg. - diabetes mellitus typ 2 - synthetika
wormax 10 flavour
loxavet pharma gmbh - febendazolo, praziquantel - febendazolo - 500 milligrammo (i); praziquantel - 50 milligrammo (i), febendazolo - 500 mg; praziquantel - 50 mg - praziquantel, combinazioni
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - asma - farmaci per le malattie respiratorie ostruttive, - budesonide / formoterolo teva pharma b. è indicato solo negli adulti dai 18 anni in su. asthmabudesonide/formoterolo teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.